Howard Hughes Medical Institute Investigator David R. Liu was awarded the 2025 Breakthrough Prize in Life Sciences for developing two gene-editing technologies—known as base editing and prime editing—which enable the correction or replacement of virtually any genetic mutation, including those that cause countless human genetic diseases.Â
Ira Mellman was named president of research at the Parker Institute for Cancer Immunotherapy.Â
Mark Cosentino has joined City of Hope as scientific director of the new Kathleen and Robert Henderson Biorepository, which is designed to be a best-in-class facility that collects and organizes tissue samples and other biological materials across City of Hope’s national system to further boost its cancer and other research.
Filippo Milano, a hematologist-oncologist and clinical researcher, was named the inaugural Endowed Chair in Cord Blood Research at Fred Hutchinson Cancer Center.
Dian Wang, William Tseng, and Brian A. Van Tine were appointed to NRG Oncology’s newly formed Sarcoma Subcommittee. Clifton (Dave) Fuller was named vice chair for NRG’s Imaging Committee.
Susan Leigh and Desirée A. H. Walker were awarded the National Coalition for Cancer Survivorship 2025 Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care.
Gabriele Casirati, of Boston Children’s Hospital, Susan E. De Wolf, of Memorial Sloan Kettering Cancer Center, Stephen Persaud, of Washington University School of Medicine, and Abdur Rehman, of the University of Texas MD Anderson Cancer Center, were awarded DKMS’ research grant in honor of John A. Hansen.
Alec C. Kimmelman was named CEO and dean of NYU Grossman School of Medicine.
Don S. Dizon will join Tufts Medicine in June 2025 as the system chief of hematology-oncology for the cancer service line. He will be proposed as the Jane F. Desforges endowed Professor in Hematology-Oncology at Tufts University School of Medicine.
Karen PollokTim LautenschlaegerJiang BianKaren Pollok was named associate director of basic science research and Tim Lautenschlaeger was named associate director of clinical research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center. Jiang Bian also recently began as chief research information officer.Â
